Retatrutide is an investigational triple agonist activating GLP-1, GIP, and glucagon receptors simultaneously, producing greater weight reduction than single or dual agonists
Lowering liver fat is important in managing or preventing progressive liver disease
Results May Vary: Individual results will vary based on factors including age, baseline health condition, starting weight, lifestyle factors, consistency of use, genetic factors, current medications, dietary adherence, physical activity levels, and other individual variables
By the time you reach maintenance dose, your tolerance is established and side effects typically plateau at mild or manageable levels
We understand that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider
Patients must follow the exact dose, concentration and injection instructions provided by their licensed healthcare provider and dispensing pharmacy